| Author(s): |
Canadian Partnership Against Cancer(CPAC) & Canadian Association of Psychosocial(CAPO) |
| Year: |
2011 |
| Description: |
Production of this guideline was made possible through a financial contribution from Health Canada,through the Canadian Partnership Against Cancer. This guideline was developed through a collaborative partnership between the Canadian Partnership Against Cancer and the Canadian Association of Psychosocial Oncology (CAPO). This practice guideline is editorially independent of the funding sources. The views and interests of the funding sources have not influenced the recommendations in this document. The views expressed here in represent the views of the National Advisory Group (acting as the Expert Panel), a sub-group of the Standards, Guidelines and Indicators Working Group of the Cancer Journey Advisory Group, Canadian Partnership Against Cancer. |